Results 281 to 290 of about 185,606 (358)
Efficacy and safety of acupuncture combined with bone-setting in the treatment of cervical vertigo: A systematic review and meta-analysis. [PDF]
Chen W +6 more
europepmc +1 more source
Abstract Background The first International Parkinson and Movement Disorder Society Evidence‐Based Medicine (MDS‐EBM) review for essential tremor (ET) was published in 2019; since then, the modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was adopted by MDS, and new evidence exists.
Deepa Dash +12 more
wiley +1 more source
Serum Vitamin D Level and Clinical Risk Factors for Benign Paroxysmal Positional Vertigo. [PDF]
Nava-Gaytán CA +3 more
europepmc +1 more source
Clinical, Genetic, and Imaging Characteristics of SCA27B: Insights from a Large Dutch Cohort
Abstract Background Deep intronic GAA repeat expansions in intron 1 of the FGF14 gene were identified in 2023 as cause of late‐onset cerebellar ataxia. Since then, GAA‐FGF14‐related ataxia (SCA27B) has emerged as one of the most common genetic causes of late‐onset cerebellar ataxia.
Teije H. van Prooije +26 more
wiley +1 more source
Diagnostic utility of smartphone-integrated gait analysis in the assessment of BPPV. [PDF]
Durmus K +6 more
europepmc +1 more source
Research shows that (R, S)‐ketamine and its stereoisomers effectively reduce symptoms of post‐traumatic stress disorder (PTSD) and treatment‐resistant depression, with (R)‐ketamine offering similar benefits with fewer side effects. Evidence highlights specific neural circuits and regions, including the dentate gyrus, prefrontal cortex, vCA3, dorsal ...
Thomas Edward Cutting +1 more
wiley +1 more source
Idiopathic Hypertrophic Pachymeningitis with Elevated Anti-Thyroglobulin Antibodies-A Case Report. [PDF]
Pobudejski P +3 more
europepmc +1 more source
ABSTRACT Introduction/Aims An On/Off dosing regimen of intravenous (IV) edaravone and edaravone oral suspension is currently approved in the US for treatment of amyotrophic lateral sclerosis (ALS). Placebo‐controlled clinical trials showed that IV edaravone slows physical functional decline.
Angela Genge +17 more
wiley +1 more source
Insights and Constraints: Understanding the Boundaries in Investigating Otosclerosis and Endolymphatic Hydrops Interaction. [PDF]
Castillo-Bustamante M +2 more
europepmc +1 more source

